(Q45731074)

English

Large-scale comparison of experimental adjuvants with herpes simplex virus vaccine reveals a correlation of protection with IgG2a and IgG2b responses

scientific article published in September 2002

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

15 December 2017

Large-scale comparison of experimental adjuvants with herpes simplex virus vaccine reveals a correlation of protection with IgG2a and IgG2b responses (English)

1 reference

Europe PubMed Central

15 December 2017

author name string

John R Simms

1

1 reference

Europe PubMed Central

15 December 2017

Roy Jennings

2

1 reference

Europe PubMed Central

15 December 2017

Vernon J Richardson

3

1 reference

Europe PubMed Central

15 December 2017

Andrew W Heath

4

1 reference

Europe PubMed Central

15 December 2017

publication date

1 September 2002

1 reference

Europe PubMed Central

15 December 2017

Journal of Medical Virology

1 reference

Europe PubMed Central

15 December 2017

68

1 reference

Europe PubMed Central

15 December 2017

82-91

1 reference

Europe PubMed Central

15 December 2017

1

1 reference

Europe PubMed Central

15 December 2017

Action of saponin on biological cell membranes

1 reference

https://api.crossref.org/works/10.1002%2FJMV.10173

21 January 2018

A comparison of commercially available adjuvants for use in research

1 reference

https://api.crossref.org/works/10.1002%2FJMV.10173

21 January 2018

Enhancement of IgG anti-carrier responses by IgG2 anti-hapten antibodies in mice.

1 reference

https://api.crossref.org/works/10.1002%2FJMV.10173

21 January 2018

Studies on experimental adjuvanted influenza vaccines: comparison of immune stimulating complexes (Iscoms) and oil-in-water vaccines.

1 reference

https://api.crossref.org/works/10.1002%2FJMV.10173

21 January 2018

IgG2a restriction of murine antibodies elicited by viral infections

1 reference

https://api.crossref.org/works/10.1002%2FJMV.10173

21 January 2018

Virally induced modulation of murine IgG antibody subclasses

1 reference

https://api.crossref.org/works/10.1002%2FJMV.10173

21 January 2018

Comparison of Freund's and Ribi adjuvants for inducing antibodies to the synthetic antigen (TG)-AL in rabbits

1 reference

https://api.crossref.org/works/10.1002%2FJMV.10173

21 January 2018

Antibody responses and protection in mice immunized with herpes simplex virus type 1 antigen immune-stimulating complex preparations

1 reference

https://api.crossref.org/works/10.1002%2FJMV.10173

21 January 2018

Efficacy of HSV-1 ISCOM vaccine in the guinea-pig model of HSV-2 infection

1 reference

https://api.crossref.org/works/10.1002%2FJMV.10173

21 January 2018

Cytotoxicity mediated by human Fc receptors for IgG.

1 reference

https://api.crossref.org/works/10.1002%2FJMV.10173

21 January 2018

The effect of paraffin oil and mycobacteria on antibody formation and sensitization; a review

1 reference

https://api.crossref.org/works/10.1002%2FJMV.10173

21 January 2018

Adjuvants for human vaccines--current status, problems and future prospects

1 reference

https://api.crossref.org/works/10.1002%2FJMV.10173

21 January 2018

Adjuvants--a balance between toxicity and adjuvanticity

1 reference

https://api.crossref.org/works/10.1002%2FJMV.10173

21 January 2018

Receptors for IgG: subclass specificity of receptors on different mouse cell types and the definition of two distinct receptors on a macrophage cell line

1 reference

https://api.crossref.org/works/10.1002%2FJMV.10173

21 January 2018

IgG subtype is correlated with efficiency of passive protection and effector function of anti-herpes simplex virus glycoprotein D monoclonal antibodies

1 reference

https://api.crossref.org/works/10.1002%2FJMV.10173

21 January 2018

Comparative studies of HSV-1 antigens solubilised from infected cells by using non-ionic or zwitterionic detergents

1 reference

https://api.crossref.org/works/10.1002%2FJMV.10173

21 January 2018

Pathogenesis of Herpes Simplex Virus in B Cell-suppressed Mice: the Relative Roles of Cell-mediated and Humoral Immunity

1 reference

https://api.crossref.org/works/10.1002%2FJMV.10173

21 January 2018

Correlation of Functional Properties of Human Lymphoid Cell Subsets and Surface Marker Phenotypes Using Multiparameter Analysis and Flow Cytometry

1 reference

https://api.crossref.org/works/10.1002%2FJMV.10173

21 January 2018

Evaluation of several adjuvants as alternatives to the use of Freund's adjuvant in rabbits

1 reference

https://api.crossref.org/works/10.1002%2FJMV.10173

21 January 2018

Comparison of adjuvants for immune potentiating properties and side effects in mice

1 reference

https://api.crossref.org/works/10.1002%2FJMV.10173

21 January 2018

IgG-mediated viral clearance in experimental infection with herpes simplex virus type 1: role for neutralization and Fc-dependent functions but not C' cytolysis and C5 chemotaxis

1 reference

https://api.crossref.org/works/10.1002%2FJMV.10173

21 January 2018

Protection against Zosteriform Spread of Herpes Simplex Virus by Monoclonal Antibodies

1 reference

https://api.crossref.org/works/10.1002%2FJMV.10173

21 January 2018

Complement-immunoglobulin interactions

1 reference

https://api.crossref.org/works/10.1002%2FJMV.10173

21 January 2018

Purified Epstein-Barr virus Mr 340,000 glycoprotein induces potent virus-neutralizing antibodies when incorporated in liposomes

1 reference

https://api.crossref.org/works/10.1002%2FJMV.10173

21 January 2018

Immune response to immunostimulatory complexes (ISCOMs) prepared from human immunodeficiency virus type 1 (HIV-1) or the HIV-1 external envelope glycoprotein (gp120).

1 reference

https://api.crossref.org/works/10.1002%2FJMV.10173

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJMV.10173

21 January 2018

Reshaping human antibodies for therapy

1 reference

https://api.crossref.org/works/10.1002%2FJMV.10173

21 January 2018

A randomized, double blind study in young healthy adults comparing cell mediated and humoral immune responses induced by influenza ISCOM? vaccines and conventional vaccines

1 reference

https://api.crossref.org/works/10.1002%2FJMV.10173

21 January 2018

Use of herpes simplex virus (HSV) type 1 ISCOMS 703 vaccine for prophylactic and therapeutic treatment of primary and recurrent HSV-2 infection in guinea pigs

1 reference

https://api.crossref.org/works/10.1002%2FJMV.10173

21 January 2018

Comparison of 24 different adjuvants for inactivated HIV-2 split whole virus as antigen in mice. Induction of titres of binding antibodies and toxicity of the formulations

1 reference

https://api.crossref.org/works/10.1002%2FJMV.10173

21 January 2018

Granuloma formation in normal guinea pigs injected intradermally with aluminum and zirconium compounds

1 reference

https://api.crossref.org/works/10.1002%2FJMV.10173

21 January 2018

Intranasal immunization of mice with herpes simplex virus type 2 recombinant gD2: the effect of adjuvants on mucosal and serum antibody responses

1 reference

https://api.crossref.org/works/10.1002%2FJMV.10173

21 January 2018

Immune responses in mice induced by HSV-1 glycoproteins presented with ISCOMs or NISV delivery systems

1 reference

https://api.crossref.org/works/10.1002%2FJMV.10173

21 January 2018

Identifiers

10.1002/JMV.10173

1 reference

Europe PubMed Central

15 December 2017

1 reference

Europe PubMed Central

15 December 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q45731074&oldid=2079019450"